1. Harnessing the potential of epigenetic therapies for childhood acute myeloid leukemia 
Ashley A. Newcombe, Brenda E.S. Gibson, Karen Keeshan 
Experimental Hematology 
Volume 63, Pages 1-11 (July 2018)
DOI: /j.exphem
Copyright © 2018 ISEH – Society for Hematology and Stem Cells Terms and Conditions

2. Figure 1
Epigenetic therapies in acute myeloid leukemia. DNA methylation, histone modifications, and associated epigenetic regulators. Epigenetic inhibitors are highlighted in red. C = cytosine; 5mC=5-methylcytosine; 5hmC=5-hydroxymethylcytosine; DNMT=DNA methyltransferase; HDAC=histone deacetylase; IDH=isocitrate dehydrogenase; 2KG=2-ketoglutarate; αKG=α-ketoglutarate; Ac=acetylation.
Experimental Hematology  , 1-11DOI: ( /j.exphem )
Copyright © 2018 ISEH – Society for Hematology and Stem Cells Terms and Conditions